The startup will use the funding to help expand its platform of patient communication and digital care solutions.
London-based startup DrDoctor has secured £3m in Series A investment from venture capital firms, Ananda Impact Ventures and 24Haymarket.
The funding will be used to expand its digital services platform and increase its reach across the United Kingdom.
The startup will also help partner trusts to break the backlog in care caused by COVID-19, including cancer care, which is now over 10 million appointments across the NHS.
- Tech startups developing rapid COVID-19 tests to be taken completely at home
- Possible Discrimination Against Remote Workforce
- Virtualization Efforts in Healthcare Support a Massive Remote Workforce
- New Healthcare Workforce Complexities Require Smarter Solutions
- Healthcare Workers Need Training, Upskilling to Realise Potential of AI
Computer vision company Gauss teamed up with biotechnology company Cellex to develop a rapid, at-home and point-of-care COVID-19 antigen test. While there are other at-home COVID-19 diagnostic tests …